Preventing recurrent preterm birth with 125 mg of 17-alpha-hydroxyprogesterone caproate.
Fukuda TomaHyo KyozukaTsuyoshi MurataShun YasudaAkiko YamaguchiKeiya FujimoriPublished in: The journal of obstetrics and gynaecology research (2021)
In this study population, weekly IM injections of 125 mg of 17-OHPC reduced the risk of recurrent PTB <37 and <34 weeks' gestation.